As a result, there is an activation of T cells seen as disturbances in subpopulations of cells ex vivo; HD patients are characterized by a reduced percentage of CD4+ cells with CD69 antigen, an early marker of activation, and an increased percentage of cells with late activation markers, like CD95 and HLA-DR [14]. The gene discussed is FAS; the disease is Huntington disease.